452 related articles for article (PubMed ID: 22092113)
1. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan.
El Maghraby GM; Elzayat EM; Alanazi FK
Drug Dev Ind Pharm; 2012 Aug; 38(8):971-8. PubMed ID: 22092113
[TBL] [Abstract][Full Text] [Related]
2. Investigation of in situ gelling alginate formulations as a sustained release vehicle for co-precipitates of dextromethrophan and Eudragit S 100.
El Maghraby GM; Elzayat EM; Alanazi FK
Acta Pharm; 2014 Mar; 64(1):29-44. PubMed ID: 24670350
[TBL] [Abstract][Full Text] [Related]
3. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
[TBL] [Abstract][Full Text] [Related]
4. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
Wittaya-areekul S; Kruenate J; Prahsarn C
Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
[TBL] [Abstract][Full Text] [Related]
6. Design and characterization of calcium-free in-situ gel formulation based on sodium alginate and chitosan.
Belhadji L; HadjSadok A; Moulai-Mostefa N
Drug Dev Ind Pharm; 2018 Apr; 44(4):662-669. PubMed ID: 29172753
[TBL] [Abstract][Full Text] [Related]
7. Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation.
Rohith G; Sridhar BK; Srinatha A
Acta Pharm; 2009 Sep; 59(3):345-54. PubMed ID: 19819830
[TBL] [Abstract][Full Text] [Related]
8. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system.
Xu Y; Zhan C; Fan L; Wang L; Zheng H
Int J Pharm; 2007 May; 336(2):329-37. PubMed ID: 17223290
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of in situ gel systems for the oral delivery of ibuprofen and its pharmacokinetics study in beagle dogs].
Wu RL; Zhao CS; Xie JW; Yi SL; Song HT; He ZG
Yao Xue Xue Bao; 2008 Sep; 43(9):956-62. PubMed ID: 19048790
[TBL] [Abstract][Full Text] [Related]
10. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
Shariff A; PK M; KLK P; M M
Pak J Pharm Sci; 2007 Jan; 20(1):1-9. PubMed ID: 17337420
[TBL] [Abstract][Full Text] [Related]
11. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
[TBL] [Abstract][Full Text] [Related]
12. Modified alginate and chitosan for lactic acid bacteria immobilization.
Le-Tien C; Millette M; Mateescu MA; Lacroix M
Biotechnol Appl Biochem; 2004 Jun; 39(Pt 3):347-54. PubMed ID: 15154848
[TBL] [Abstract][Full Text] [Related]
13. Phase transition system: novel oral in-situ gel.
Nagarwal RC; Pandit JK
Curr Drug Deliv; 2008 Oct; 5(4):282-9. PubMed ID: 18855597
[TBL] [Abstract][Full Text] [Related]
14. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme.
Rawat M; Singh D; Saraf S; Saraf S
Drug Dev Ind Pharm; 2008 Feb; 34(2):181-8. PubMed ID: 18302037
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
16. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
17. In situ gelling formulation based on methylcellulose/pectin system for oral-sustained drug delivery to dysphagic patients.
Itoh K; Hatakeyama T; Shimoyama T; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2011 Jul; 37(7):790-7. PubMed ID: 21405940
[TBL] [Abstract][Full Text] [Related]
18. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats.
Onishi H; Koyama K; Sakata O; Machida Y
Drug Dev Ind Pharm; 2010 Aug; 36(8):879-84. PubMed ID: 20345284
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
Khan N; Aqil M; Imam SS; Ali A
Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
[TBL] [Abstract][Full Text] [Related]
20. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
Chatchawalsaisin J; Podczeck F; Newton JM
Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
